Back
CRISPR Therapeutics AG Stock Price Chart

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
7
CRSP
CRISPR Therapeutics AG
Last Price:
$42.18
Seasonality Move:
13.67%
7 Day Trial
ALL ACCESS PASS
$
7

Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
CRISPR Therapeutics AG Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.97 | Sell |
20-day SMA: | 43.57 | Sell |
50-day SMA: | 42.79 | Sell |
200-day SMA: | 48.39 | Sell |
8-day EMA: | 16.28 | Buy |
20-day EMA: | 7.47 | Buy |
50-day EMA: | 3.17 | Buy |
200-day EMA: | 0.82 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.82 | Buy |
Relative Strength Index (14 RSI): | 43.68 | Sell |
Chaikin Money Flow: | 424411 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.17 - 47.87) | Sell |
Bollinger Bands (100): | (40.64 - 49.26) | Sell |
CRISPR Therapeutics AG Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 41.22 while CRSP 8-day simple moving average is 41.97, which is a Sell signal.
-
The stock price of CRSP is 41.22 while CRISPR Therapeutics AG 20-day SMA is 43.57, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day simple moving average is 42.79 while CRSP share price is 41.22, making it a Sell technically.
-
CRSP stock price is 41.22 and CRISPR Therapeutics AG 200-day simple moving average is 48.39, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
7
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $41.22. The Score for CRSP is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
3.5B
Price in USD:
41.22
Share Volume:
1.5M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
74.59
52-Week Low:
36.52
Sell
7
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 41.22 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 41.22 while CRSP 8-day exponential moving average is 16.28, which is a Buy signal.
-
The stock price of CRSP is 41.22 while CRISPR Therapeutics AG 20-day EMA is 7.47, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 3.17 while CRSP share price is 41.22, making it a Buy technically.
-
CRSP stock price is 41.22 and CRISPR Therapeutics AG 200-day simple moving average is 0.82, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.06 per share, an increase this year of $0.22 per share, and an increase next year of $0.93 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 5.82, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 43.68, which suggest CRISPR Therapeutics AG is oversold
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (41.17 - 47.87), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (40.64 - 49.26), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.